Literature DB >> 26430665

Efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive in Korean women.

Nayoung Kim1, Ha-Na Yoo1, Hye Sun Hyun1, Dong-Yun Lee1, Byung-Koo Yoon1, Doo-Seok Choi1.   

Abstract

This study assesses the efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive, and demonstrates that it is an effective and safe option for contraception, releasing symptom of premenstrual dysphoric disorder and acne in Korean women.

Entities:  

Keywords:  Contraceptives, oral, combined; Efficacy; Korea; Safety

Year:  2015        PMID： 26430665      PMCID： PMC4588845          DOI： 10.5468/ogs.2015.58.5.397

Source DB:  PubMed          Journal:  Obstet Gynecol Sci        ISSN： 2287-8572


  13 in total

Review 1.  Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis.

Authors:  Ellen W Freeman
Journal:  Psychoneuroendocrinology       Date:  2003-08       Impact factor: 4.905

2.  Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons.

Authors:  M J Rosenberg; M S Waugh
Journal:  Am J Obstet Gynecol       Date:  1998-09       Impact factor: 8.661

Review 3.  The premenstrual syndrome. A review.

Authors:  P M O'Brien
Journal:  J Reprod Med       Date:  1985-02       Impact factor: 0.142

Review 4.  The use of newer progestins for contraception.

Authors:  Regine Sitruk-Ware; Anita Nath
Journal:  Contraception       Date:  2010-05-11       Impact factor: 3.375

Review 5.  Contraceptive failure in the United States.

Authors:  James Trussell
Journal:  Contraception       Date:  2011-03-12       Impact factor: 3.375

6.  Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone.

Authors:  Gloria Bachmann; Patricia J Sulak; Carole Sampson-Landers; Norbert Benda; Joachim Marr
Journal:  Contraception       Date:  2004-09       Impact factor: 3.375

7.  Efficacy of a low-dose oral contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for the treatment of moderate acne: A randomized, placebo-controlled trial.

Authors:  James Leyden; Alan Shalita; Maria Hordinsky; Leonard Swinyer; Frank Z Stanczyk; Margaret E Weber
Journal:  J Am Acad Dermatol       Date:  2002-09       Impact factor: 11.527

8.  The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study.

Authors:  A van Hylckama Vlieg; F M Helmerhorst; J P Vandenbroucke; C J M Doggen; F R Rosendaal
Journal:  BMJ       Date:  2009-08-13

9.  Hormonal contraception and risk of venous thromboembolism: national follow-up study.

Authors:  Øjvind Lidegaard; Ellen Løkkegaard; Anne Louise Svendsen; Carsten Agger
Journal:  BMJ       Date:  2009-08-13

10.  A comparative efficacy of low-dose combined oral contraceptives containing desogestrel and drospirenone in premenstrual symptoms.

Authors:  Jirath Wichianpitaya; Surasak Taneepanichskul
Journal:  Obstet Gynecol Int       Date:  2013-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.